Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE will be a prominent presence at the 2024 Excipient World meeting in Florida, with a presentation of the strengths of its lactose-based InhaLac® range for dry powder inhaler (DPI) applications.
MEGGLE Appoints Barentz as its Exclusive Distributor of Pharmaceutical-Grade Lactose for United States
LBB takes on the marketing and distribution of Meggle’s lactose-based excipients for direct compression and inhalation in the US market.
LBB Specialties announced that effective August 1, 2019, LBB has entered into a strategic partnership with MEGGLE Excipients & Technology to distribute MEGGLE's excipient products to companies in the American pharmaceutical and nutraceutical industries. LBB Specialties' subsidiary companies, American International Chemical (AIC) and Charkit Chemical Company, will share responsibility for sales, marketing and distribution efforts for MEGGLE products in the US market.
MEGGLE brings advanced co-processed and DPI excipients to FCE Pharma Brazil